The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Share Buy-back Programme

23 Jan 2018 14:43

RNS Number : 6987C
FastForward Innovations Limited
23 January 2018
 

23 January 2018

 

 

FastForward Innovations Ltd

("FastForward" or the "Company")

Extension of Share Buy-Back Programme

Compliance with Market Abuse Regulation

FastForward Innovations Limited (AIM: FFWD) (the "Company") today announces that the share buy-back programme announced by the Company on 20 November 2017 has been extended until 28 February 2018 (the "Extended Period").

As at 19 January 2018, the Company had redeemed in aggregate 790,000 shares at an average price of £0.16.

During the Extended Period the Company has approved the redemption of up to a maximum of 3,400,000 further shares (the "Extended Buy-Back Programme"). The Extended Buy-Back Programme will be funded from existing cash resources and is being undertaken given the Directors' belief that the current market price, particularly given the recent listing of Nuuvera Inc. and positive developments across the Company's portfolio of investments in 2017,. significantly undervalues the underlying value of the Company's investment portfolio.

Any purchase of Ordinary Shares made in relation to this announcement will be carried out on the open market during the period commencing on 22 January and ending not later than 28 February 2018.

The Extended Buy-Back Programme shall be executed in accordance with the Company's general authority to make market purchases of Ordinary Shares as approved by Shareholders on 16 September 2016 and those provisions of Market Abuse Regulation 596/2014/EU dealing with buy-back programmes including in particular in relation to trading restrictions regarding time and volume, disclosure and reporting obligations, and price conditions set out under Market Abuse Regulation 596/2014/EU.

The shares purchased by the Company will be held in treasury pending cancellation. Optiva Securities Limited is the Company's broker in relation to the Programme:

Name of Programme

2017 - 2018 Share Buy-Back Programme

Purpose of the Programme

To reduce the capital of the issuer

Duration of the Programme

20 November 2017 to 28 February 2018

Maximum amount allocated to the Programme

US$900,000 (approximately £652,646)

Maximum number of shares to be acquired

Up to 3,400,000 ordinary shares

Maximum price

 

The higher of:

a) the price of the last independent trade; and

b) the highest current independent purchase bid on the trading venue where the purchase is carried out.

Maximum size of purchase on any trading day

25% of the average daily volume of the shares on the trading venue on which the purchase is carried out, such average daily volume calculated over the 20 trading days preceding the date of purchase

 

 

FastForward Innovations Limited

info@fstfwd.co

Sue Saunders / Ian Burns

 

Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396

James Biddle / Roland Cornish

 

Optiva Securities Limited (Broker) Tel: +44 (0) 203 411 1881

Ed McDermott

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of Fast Forward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Fast Forward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDBBSDBGIX
Date   Source Headline
23rd Jul 20187:00 amRNSAgreement
19th Jul 201812:40 pmRNSFurther investment in Intensity Therapeutics Inc.
9th Jul 201811:17 amRNSIncreased holding in Fralis LLC (Leap Gaming)
6th Jul 20185:44 pmRNSResults for the year ended 31st March 2018
22nd Jun 20182:30 pmRNSInvestment in Vogogo Inc. Conv. Debenture Units
20th Jun 20186:20 pmRNSInvestee Company Update
19th Jun 20187:00 amRNSInvestment in Juvenescence Limited
12th Jun 20187:00 amRNSInvestee Company Update: Subscription into Fralis
11th Jun 20189:53 amRNSSale of Aphria Shares
16th May 20187:00 amRNSRegulatory Approval
23rd Mar 20183:35 pmRNSInvestee Company Update: Nuuvera Inc.
21st Mar 20181:28 pmRNSInvestee Company Update: Nuuvera
12th Mar 20181:00 pmRNSKey Investor Document
7th Mar 20182:34 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSProposed Director's Dealing
27th Feb 20183:43 pmRNSInvestee Company Update: Intensity Therapeutics
26th Feb 20184:01 pmRNSInvestee Company Update: Nuuvera
20th Feb 20183:26 pmRNSInvestee Company Update: Nuuvera
13th Feb 201812:22 pmRNSDirector Appointment
13th Feb 201812:05 pmRNSResult of AGM
12th Feb 20184:51 pmRNSTransaction in Own Shares
6th Feb 20189:37 amRNSCorrection of Notice of AGM
2nd Feb 20189:35 amRNSInvestee Company Update: Vemo
31st Jan 201811:04 amRNSTransaction in Own Shares
30th Jan 20185:00 pmRNSNotice of AGM
30th Jan 20184:20 pmRNSNotice of AGM
30th Jan 20188:35 amRNSHolding(s) in Company
29th Jan 20181:33 pmRNSInvestee Company Update: Nuuvera
23rd Jan 20182:43 pmRNSExtension of Share Buy-back Programme
23rd Jan 20181:19 pmRNSTransaction in Own Shares
18th Jan 20183:18 pmRNSInvestment Company Updates: Nuuvera
16th Jan 20183:36 pmRNSInvestee Company Update: Nuuvera
12th Jan 20183:43 pmRNSInvestee Company Update: Nuuvera
12th Jan 20182:23 pmRNSInvestee Company Update: Nuuvera
11th Jan 20188:00 amRNSInvestee Company Update: Nuuvera
8th Jan 20187:00 amRNSInvestee Company Update: Nuuvera
2nd Jan 201811:26 amRNSInvestee Company update: Nuuverra transaction
28th Dec 20173:29 pmRNSHalf-year Report
15th Dec 20179:23 amRNSCompany Secretary Change
15th Dec 20177:00 amRNSInvestee Company Update: Nuuvera
29th Nov 20174:14 pmRNSTransaction in Own Shares
29th Nov 20177:00 amRNSHolding(s) in Company
28th Nov 20174:06 pmRNSTransaction in Own Shares
23rd Nov 201710:12 amRNSHolding(s) in Company
20th Nov 201710:30 amRNSShare Buy-Back Programme
20th Nov 20179:56 amRNSMarket Update
3rd Nov 201712:00 pmRNSInvestee Company Update
9th Oct 20177:00 amRNSUpdate on Nuuverra Investment
18th Sep 20177:00 amRNSDisposal of interest in investee company
15th Aug 20177:00 amRNSInvestee Company Update: Schoold

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.